Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating Pain Management Practices for Cancer Patients among Health Professionals: A Global Survey.
Silbermann M, Calimag MM, Eisenberg E, Futerman B, Fernandez-Ortega P, Oliver A, Yaeger Monje JP, Guo P, Charalambous H, Nestoros S, Pozo X, Bhattacharyya G, Katz GJ, Tralongo P, Fujisawa D, Kunirova G, Punjwani R, Ayyash H, Ghrayeb I, Manasrah N, Bautista MJS, Kotinska-Lemieszek A, de Simone G, Cerutti J, Gafer N, Can G, Terzioglu F, Kebudi R, Tuncel-Oguz G, Aydin A, Ozalp Şenel G, Mwaka AD, Youssef A, Brant J, Alvarez GP, Weru J, Rudilla D, Fahmi R, Hablas M, Rassouli M, Mula-Hussain L, Faraj S, Al-Hadad S, Al-Jadiry M, Ghali H, Fadhil SA, Abu-Sharour L, Omran S, Al-Qadire M, Hassan A, Khader K, Alalfi N, Ahmed G, Galiana L, Sansó N, Abe A, Vidal-Blanco G, Rochina A. Silbermann M, et al. Among authors: tralongo p. J Palliat Med. 2022 Aug;25(8):1243-1248. doi: 10.1089/jpm.2021.0596. Epub 2022 Apr 18. J Palliat Med. 2022. PMID: 35442772 Free article.
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Cazzaniga ME, Vallini I, Montagna E, Amoroso D, Berardi R, Butera A, Cagossi K, Cavanna L, Ciccarese M, Cinieri S, Cretella E, De Conciliis E, Febbraro A, Ferraù F, Ferzi A, Baldelli A, Fontana A, Gambaro AR, Garrone O, Gebbia V, Generali D, Gianni L, Giovanardi F, Grassadonia A, Leonardi V, Marchetti P, Sarti S, Musolino A, Nicolini M, Putzu C, Riccardi F, Santini D, Saracchini S, Sarobba MG, Schintu MG, Scognamiglio G, Spadaro P, Taverniti C, Toniolo D, Tralongo P, Turletti A, Valenza R, Valerio MR, Vici P, Di Mauro P, Cogliati V, Capici S, Clivio L, Torri V; VICTOR Study Group. Cazzaniga ME, et al. Among authors: tralongo p. Breast Cancer Res Treat. 2021 Dec;190(3):415-424. doi: 10.1007/s10549-021-06375-5. Epub 2021 Sep 21. Breast Cancer Res Treat. 2021. PMID: 34546500 Free PMC article.
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Cazzaniga ME, Pinotti G, Montagna E, Amoroso D, Berardi R, Butera A, Cagossi K, Cavanna L, Ciccarese M, Cinieri S, Cretella E, De Conciliis E, Febbraro A, Ferraù F, Ferzi A, Fiorentini G, Fontana A, Gambaro AR, Garrone O, Gebbia V, Generali D, Gianni L, Giovanardi F, Grassadonia A, Leonardi V, Marchetti P, Melegari E, Musolino A, Nicolini M, Putzu C, Riccardi F, Santini D, Saracchini S, Sarobba MG, Schintu MG, Scognamiglio G, Spadaro P, Taverniti C, Toniolo D, Tralongo P, Turletti A, Valenza R, Valerio MR, Vici P, Clivio L, Torri V; VICTOR Study Group. Cazzaniga ME, et al. Among authors: tralongo p. Breast. 2019 Dec;48:7-16. doi: 10.1016/j.breast.2019.07.006. Epub 2019 Aug 22. Breast. 2019. PMID: 31470257
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
Gebbia V, Verderame F, Ferraù F, Bordonaro R, Callari A, Caruso M, Tirrito ML, Valenza R, Cicero G, Borsellino N, Tralongo P. Gebbia V, et al. Among authors: tralongo p. Ann Oncol. 2006 Jun;17 Suppl 7:vii60-5. doi: 10.1093/annonc/mdl953. Ann Oncol. 2006. PMID: 16760296 Free article. Clinical Trial.
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.
Gebbia V, Maiello E, Giuliani F, Borsellino N, Caruso M, Di Maggio G, Ferraù F, Bordonaro R, Verderame F, Tralongo P, Di Cristina L, Agueli R, Russo P, Colucci G. Gebbia V, et al. Among authors: tralongo p. Ann Oncol. 2007 Jun;18 Suppl 6:vi124-7. doi: 10.1093/annonc/mdm240. Ann Oncol. 2007. PMID: 17591805 Free article.
Patients' preference and informed consent.
Pumo V, Di Mari A, Rametta Giuliano S, Bordonaro S, Lanteri E, Tralongo P. Pumo V, et al. Among authors: tralongo p. Ann Oncol. 2015 Jun;26(6):1269. doi: 10.1093/annonc/mdv143. Epub 2015 Mar 18. Ann Oncol. 2015. PMID: 25787921 Free article. No abstract available.
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).
Di Costanzo F, Carlini P, Doni L, Massidda B, Mattioli R, Iop A, Barletta E, Moscetti L, Recchia F, Tralongo P, Gasperoni S. Di Costanzo F, et al. Among authors: tralongo p. Br J Cancer. 2005 Jul 25;93(2):185-9. doi: 10.1038/sj.bjc.6602640. Br J Cancer. 2005. PMID: 15986036 Free PMC article. Clinical Trial.
90 results